These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6674080)

  • 1. [Immunotherapy of allergic diseases--present and future].
    Reshef A; Alroy G
    Harefuah; 1983 Dec; 105(12):436-8. PubMed ID: 6674080
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-injection routes for immunotherapy of allergic diseases.
    Valovirta E; Passalacqua G; Canonica WG
    Clin Allergy Immunol; 2004; 18():607-23. PubMed ID: 15042938
    [No Abstract]   [Full Text] [Related]  

  • 3. [Does immunotherapy of allergy have any future?].
    Foucard T
    Lakartidningen; 1994 May; 91(19):1922-4. PubMed ID: 8189936
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunomodulation: the future cure for allergic diseases.
    Tsitoura DC; Tassios Y
    Ann N Y Acad Sci; 2006 Nov; 1088():100-15. PubMed ID: 17192559
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Specific immunotherapy--past--present--future].
    Kägi MK
    Praxis (Bern 1994); 1998 Sep; 87(40):1330-4. PubMed ID: 9816927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutics of the future for allergy].
    Sibille G
    Allerg Immunol (Paris); 1999 Apr; 31(4):120-1. PubMed ID: 10370726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for appropriate sublingual immunotherapy clinical trials.
    Casale TB; Canonica GW; Bousquet J; Cox L; Lockey R; Nelson HS; Passalacqua G
    J Allergy Clin Immunol; 2009 Oct; 124(4):665-70. PubMed ID: 19766297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hyposensitization treatment of allergic diseases].
    Wüthrich B
    Schweiz Rundsch Med Prax; 1993 May; 82(18):529-33. PubMed ID: 8497762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific immunotherapy in the U.S.A.: general concept and recent initiatives.
    Esch RE
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003; (94):17-22; discussion 23. PubMed ID: 15119018
    [No Abstract]   [Full Text] [Related]  

  • 10. Sublingual immunotherapy.
    Heinzerling L; Worm M; Bergmann KC; Zuberbier T
    J Dtsch Dermatol Ges; 2006 May; 4(5):428-33; quiz 434-5. PubMed ID: 16686612
    [No Abstract]   [Full Text] [Related]  

  • 11. [A new boost for 100-year old therapy].
    Hedlin G
    Lakartidningen; 2008 Jun 25-Jul 1; 105(26-27):1931. PubMed ID: 18681373
    [No Abstract]   [Full Text] [Related]  

  • 12. Allergen immunotherapy.
    Wild LG; Lopez M
    J La State Med Soc; 2001 May; 153(5):246-55. PubMed ID: 11433933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in upper airway diseases and allergen immunotherapy in 2007.
    Saltoun C; Avila PC
    J Allergy Clin Immunol; 2008 Sep; 122(3):481-7. PubMed ID: 18694591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Our experience with the treatment of otorhinolaryngological allergic diseases with the use of the subtivaccine].
    Dodvinec S; Mitrović K; Vucicević B; Djoković C; Mijanović R
    Srp Arh Celok Lek; 1965; 93(7):669-76. PubMed ID: 5884868
    [No Abstract]   [Full Text] [Related]  

  • 15. [Practical aspects of specific immunotherapy].
    Breborowicz A
    Pol Merkur Lekarski; 2003 Jun; 14(84):692-4. PubMed ID: 14524307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergy immunotherapy for primary care physicians.
    Stokes JR; Casale TB
    Am J Med; 2006 Oct; 119(10):820-3. PubMed ID: 17000208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine-based immunotherapy of allergic disease.
    Lewkowich IP; HayGlass KT
    Arch Immunol Ther Exp (Warsz); 2001; 49(4):293-302. PubMed ID: 11726032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TLR9-based immunotherapy for allergic disease.
    Hayashi T; Raz E
    Am J Med; 2006 Oct; 119(10):897.e1-6. PubMed ID: 17000223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunotherapy in patients allergic to hymenoptera venom].
    Lorente Toledano F; Romo Cortina A; García Romo MJ; de Dios Martín B
    Allergol Immunopathol (Madr); 1996; 24 Suppl 1():84-92. PubMed ID: 8815727
    [No Abstract]   [Full Text] [Related]  

  • 20. Subcutaneous immunotherapy for allergic rhinoconjunctivitis, allergic asthma, and prevention of allergic diseases.
    Malling HJ; Bousquet J
    Clin Allergy Immunol; 2008; 21():343-58. PubMed ID: 18828516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.